Sequencing Agents to Treat Castration-Resistant Prostate Cancer

Publication
Article
Special ReportsGenitourinary Cancers
Volume 1
Issue 1

Leonard G. Gomella, MD, FACS, Department of Urology, Thomas Jefferson University, Associate Director, Clinical Affairs, Kimmel Cancer Center, comments on sequencing agents to treat castration-resistant prostate cancer.

Leonard G. Gomella, MD, FACS, Chair and Professor, Department of Urology, Thomas Jefferson University, Associate Director, Clinical Affairs, Kimmel Cancer Center, comments on sequencing agents to treat castration-resistant prostate cancer (CRPC).

Read more about immunotherapy for the treatment of CRPC > >

Related Videos
Related Content